What Seattle's Biotech Community Gained When It Lost Amgen

Marcie Sillman talks to Luke Timmerman, founder and editor of the Timmerman Report, about Juno Therapeutics and other biotech startups like Just Biotherapeutics that came out of the closure of Amgen's Seattle offices last year.